CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 4 Planned sale Director sold 14,000 shares at an average $226.49 ($3,170,846)
- 4 Planned sale Director sold 12,780 shares at an average $219.85 ($2,809,689)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 4,570 shares at an average $197.61 ($903,093)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale EXECUTIVE CHAIRMAN sold 22,900 shares at an average $200.51 ($4,591,674)
- 4 Planned sale Director sold 4,000 shares at an average $200.07 ($800,274)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $198.60 ($595,810)
- 4 Grant or award Director acquired 97 shares (grant or award)
- 4 Planned sale Director sold 122 shares at $198.71 ($24,243)
- 4 Grant or award Director acquired 128 shares (grant or award)
- 4 Grant or award Director acquired 149 shares (grant or award)
- 4 Grant or award Director acquired 93 shares (grant or award)
- 4 Grant or award Director acquired 93 shares (grant or award)
- 144 Insider Sale of Securities
- 4 Planned sale CEO AND PRESIDENT sold 160,703 shares at an average $199.96 ($32,133,981)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 17,100 shares at $200.00 ($3,420,003)
Page 16 of 94 · 1,862 filings